Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

7.1%

52 terminated/withdrawn out of 731 trials

Success Rate

86.0%

-0.5% vs industry average

Late-Stage Pipeline

11%

77 trials in Phase 3/4

Results Transparency

9%

28 of 320 completed trials have results

Key Signals

127 recruiting28 with results35 terminated17 withdrawn

Enrollment Performance

Analytics

N/A
397(65.8%)
Phase 2
74(12.3%)
Phase 1
49(8.1%)
Phase 3
46(7.6%)
Phase 4
31(5.1%)
Early Phase 1
6(1.0%)
603Total
N/A(397)
Phase 2(74)
Phase 1(49)
Phase 3(46)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (731)

Showing 20 of 731 trials
NCT06014424Phase 2Recruiting

Cannabidiol Medication Intervention Trial

Role: lead

NCT07476781Not ApplicableRecruiting

Exploring the Feasibility of Cerebrospinal Fluid (CSF) and Blood Plasma Liquid Biopsy in Patients With Metastatic Solid Tumours and Primary Central Nervous System (CNS) Tumours: A Pilot Study

Role: lead

NCT03617562Not ApplicableRecruiting

Superior Capsular Reconstruction vs. Partial Repair for Massive Rotator Cuff Tears

Role: lead

NCT05097586Not ApplicableRecruiting

RCT of At-Home tDCS for Depression in Pregnancy

Role: collaborator

NCT07477431Phase 2Recruiting

Levetiracetam for Persons at Risk for Alzheimer's Disease

Role: lead

NCT05592938Not ApplicableRecruiting

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Role: collaborator

NCT07707492Not ApplicableNot Yet Recruiting

Better Access to and Integration of Mental Health and Addiction Services Through Navigation: A Mixed-Methods Adaptive Pragmatic Clinical Trial

Role: lead

NCT07704632Not ApplicableRecruiting

Safety and Feasibility of FUS Next Generation Dome Helmet (NGDH) to Perform Neuromodulation in Patients With Treatment Refractory Obsessive Compulsive Disorder (OCD)

Role: lead

NCT07193953Phase 1Active Not Recruiting

Intravenous Immunoglobulin (IVIG) and Blood-Brain Barrier Disruption in Amyotrophic Lateral Sclerosis (ALS)

Role: lead

NCT07694258Not ApplicableRecruiting

Assessment of Safety and Feasibility of FUS Next Generation Dome Helmet (NGDH) to Perform Neuromodulation in Patients With Disorders of Consciousness

Role: lead

NCT07684976Not ApplicableRecruiting

Safety and Feasibility of Next-Generation Dome Helmet (NGDH) for Focused Ultrasound Neuromodulation in Substance Use Disorder (SUD)

Role: lead

NCT05720078Not ApplicableActive Not Recruiting

UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-3 (UNITED-3)

Role: lead

NCT07674225Not ApplicableActive Not Recruiting

Dose-Escalated MR-Guided Radiotherapy for Localized Prostate Cancer

Role: lead

NCT04619069Phase 1Active Not Recruiting

Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer

Role: lead

NCT06322537Active Not Recruiting

Albumin Utilization in Adult Cardiac Surgical Patients: Retrospective

Role: collaborator

NCT07656636Not ApplicableNot Yet Recruiting

Perforated Appendicitis and Postoperative Antibiotics Pilot Trial

Role: collaborator

NCT06849596Not ApplicableRecruiting

Manual T-piece Versus Ventilator Positive Pressure Ventilation During Resuscitation of Extremely Premature Neonates

Role: collaborator

NCT06363266Not ApplicableRecruiting

A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers

Role: collaborator

NCT03358303Not ApplicableActive Not Recruiting

Effects of Telemonitoring on the Outcome of Heart Failure Patients After an Incidence of Acute Decompensation

Role: collaborator

NCT06177093Not ApplicableRecruiting

Pilot Study of Dose Escalation in Prostate Radiotherapy Using the MR-Linac (DESTINATION-MRL)

Role: lead